首页> 外国专利> SYSTEMIC PRO-HEMOSTATIC EFFECT OF CLOTTING FACTORS IN COMBINATION WITH SYMPATHICOMIMETICS WITH AGONISTIC EFFECTS ON α-ADRENERGIC AND/OR β-ADRENERGIC RECEPTORS OF THE SYMPATHETIC NERVOUS SYSTEM, RELATED TO IMPROVED CLOT STRENGTH.

SYSTEMIC PRO-HEMOSTATIC EFFECT OF CLOTTING FACTORS IN COMBINATION WITH SYMPATHICOMIMETICS WITH AGONISTIC EFFECTS ON α-ADRENERGIC AND/OR β-ADRENERGIC RECEPTORS OF THE SYMPATHETIC NERVOUS SYSTEM, RELATED TO IMPROVED CLOT STRENGTH.

机译:凝血因子与交感神经同种疗法和结合性结合对凝血神经系统的α-肾上腺素和/或β-肾上腺素受体的全身止血作用,与改善的血栓强度有关。

摘要

The present invention relates to a novel use and methods of treatment using the combination of clotting factors and sympathicomimetic / adrenergic receptor agonists with pro-hemostatic activity. Administration of a combination of clotting factors and sympathicomimetic / adrenergic receptor agonists increases blood clot strength as visualized by TEG analyses. The compounds of the invention are particularly useful in the treatment of trauma patients.
机译:本发明涉及使用凝血因子和具有止血活性的拟交感神经/肾上腺素能受体激动剂的组合的新颖用途和治疗方法。 TEG分析显示,凝血因子和拟交感神经/肾上腺素能受体激动剂的组合给药可增加血液凝块强度。本发明的化合物在治疗创伤患者中特别有用。

著录项

  • 公开/公告号WO2010149172A3

    专利类型

  • 公开/公告日2011-04-07

    原文格式PDF

  • 申请/专利权人 RIGSHOSPITALET;JOHANSSON PÄR;

    申请/专利号WO2010DK50163

  • 发明设计人 JOHANSSON PÄR;

    申请日2010-06-24

  • 分类号A61K38/36;A61K38/37;A61P7;A61K31;A61K31/137;A61P7/04;

  • 国家 WO

  • 入库时间 2022-08-21 18:00:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号